Dr Pradeep Mahajan, Regenerative Medicine Researcher & Founder of StemRx BioScience Solutions India. In the wake of the COVID-19 pandemic, the world witnessed an unprecedented health crisis that affected millions of lives. While many individuals recovered from the infection, some continue to experience long-term complications. One
Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp). The virus is incapable of developing resistance to favipiravir even with long-term exposure on infected cells, as has been confirmed
